Arterial Permeability and Efflux of Apolipoprotein B–Containing Lipoproteins Assessed by In Situ Perfusion and Three-Dimensional Quantitative Confocal Microscopy

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,756 · see citing works

Atherogenesis: a postprandial phenomenon.

Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701 · see citing works

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J. (2002) · Nature · doi:10.1038/nature00804 · Cited by 1,019 · see citing works

Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries.

Schwenke, D. C., & Carew, T. E. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.6.908 · Cited by 344 · see citing works

Selective Retention of VLDL, IDL, and LDL in the Arterial Intima of Genetically Hyperlipidemic Rabbits In Vivo: Molecular Size as a Determinant of Fractional Loss From the Intima–Inner Media

Nordestgaard, B. G., Wootton, R., & Lewis, B. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.4.534 · Cited by 334 · see citing works

Comparison of Apolipoprotein and Proteoglycan Deposits in Human Coronary Atherosclerotic Plaques

O’Brien, K. D., Olin, K. L., Alpers, C. E., Chiu, W. S., Ferguson, M. S., Hudkins, K. L., Wight, T. N., & Chait, A. (1998) · Circulation · doi:10.1161/01.cir.98.6.519 · Cited by 271 · see citing works

Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity

Kwiterovich, P. O. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02749-2 · Cited by 207 · see citing works

Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis

Proctor, S. D., Vine, D. F., & Mamo, J. C. L. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00001 · Cited by 200 · see citing works

Cellular Consequences of the Association of ApoB Lipoproteins With Proteoglycans

Hurt‐Camejo, E., Olsson, U., Wiklund, O., Bondjers, G., & Camejo, G. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.6.1011 · Cited by 165 · see citing works

Heparan Sulfate Proteoglycans Participate in Hepatic Lipaseand Apolipoprotein E-mediated Binding and Uptake of Plasma Lipoproteins, Including High Density Lipoproteins

Ji, Z.-S., Dichek, H. L., Miranda, R. D., & Mahley, R. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31285 · Cited by 156 · see citing works

Retention of fluorescent‐labelled chylomicron remnants within the intima of the arterial wall — evidence that plaque cholesterol may be derived from post‐prandial lipoproteins

Proctor, S. D., & Mamo, J. C. L. (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00317.x · Cited by 147 · see citing works

Low density lipoprotein size, pravastatin treatment, and coronary events.

Campos, H. (2001) · JAMA · doi:10.1001/jama.286.12.1468 · Cited by 132 · see citing works

Intimal Retention of Cholesterol Derived From Apolipoprotein B100– and Apolipoprotein B48–Containing Lipoproteins in Carotid Arteries of Watanabe Heritable Hyperlipidemic Rabbits

Proctor, S. D., & Mamo, J. C. L. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000084638.14534.0a · Cited by 124 · see citing works

ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan

Olin-Lewis, K., Krauss, R. M., La Belle, M., Blanche, P. J., Barrett, P. H. R., Wight, T. N., & Chait, A. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200322-jlr200 · Cited by 114 · see citing works

Lipoprotein Lipase in the Arterial Wall

Pentikäinen, M. O., Oksjoki, R. K., Öörni, K., & Kovanen, P. T. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0102.101551 · Cited by 108 · see citing works

Identification of the Proteoglycan Binding Site in Apolipoprotein B48

Flood, C., Gustafsson, M. V., Richardson, P. E., Harvey, S. C., Segrest, J. P., & Borén, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204053200 · Cited by 107 · see citing works

Atherogenic Lipoprotein Phenotype and Diet-Gene Interactions

Krauss, R. M. (2001) · Journal of Nutrition · doi:10.1093/jn/131.2.340s · Cited by 101 · see citing works

Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin

Mamo, J. C. L., & Wheeler, J. R. (1994) · Coronary Artery Disease · doi:10.1097/00019501-199408000-00008 · Cited by 100 · see citing works

Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma

Mamo, J. C. L., Proctor, S. D., & Smith, D. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00220-2 · Cited by 98 · see citing works

Role of extracellular retention of low density lipoproteins in atherosclerosis

Borén, J., Gustafsson, M. V., Skålén, K., Flood, C., & Innerarity, T. L. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200010000-00002 · Cited by 75 · see citing works

Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Lack of evidence for an independent chylomicron-remnant receptor

Bowler, A., Redgrave, T. G., & Mamo, J. C. L. (1991) · Biochemical Journal · doi:10.1042/bj2760381 · Cited by 72 · see citing works

The extracellular matrix on atherogenesis and diabetes-associated vascular disease

Camejo, G., Olsson, U., Hurt‐Camejo, E., Baharamian, N., & Bondjers, G. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(01)00005-8 · Cited by 63 · see citing works

Arterial fatty lesions have increased uptake of chylomicron remnants but not low-density lipoproteins.

Proctor, S. D., & Mamo, J. C. L. (1996) · PubMed · Cited by 58 · see citing works

Biglycan, a Vascular Proteoglycan, Binds Differently to HDL 2 and HDL 3

Olin, K. L., Potter‐Perigo, S., Barrett, P. H. R., Wight, T. N., & Chait, A. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.1.129 · Cited by 45 · see citing works

A Highly Sensitive Assay for Quantitation of Apolipoprotein B 48 Using an Antibody to Human Apolipoprotein B and Enhanced Chemiluminescence

Smith, D., Proctor, S. D., & Mamo, J. C. L. (1997) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329703400210 · Cited by 45 · see citing works

Lipoprotein lipase-enhanced binding of human triglyceride-rich lipoproteins to heparan sulfate: modulation by apolipoprotein E and apolipoprotein C

van Barlingen, H. H. J. J., de Jong, H., Erkelens, D. W., & de Bruin, T. W. A. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37573-8 · Cited by 39 · see citing works

Cellular Interactions of Lipoproteins with the Vascular Endothelium: Endocytosis and Transcytosis

Simionescu, N. I. C., & Simionescu, M. A. Y. (2017) · Routledge eBooks · doi:10.1201/9780203748831-2 · Cited by 30 · see citing works

Arterial intimal retention of pro-atherogenic lipoproteins in insulin deficient rabbits and rats

Proctor, S. D., Pabla, C. K., & Mamo, J. C. L. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00341-x · Cited by 29 · see citing works

Apolipoprotein E and Lipoprotein Lipase Increase Triglyceride-Rich Particle Binding but Decrease Particle Penetration in Arterial Wall

Mullick, A. E., Deckelbaum, R. J., Goldberg, I. J., Al-Haideri, M. T., & Rutledge, J. C. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000040221.70377.19 · Cited by 24 · see citing works

Is the Size of Low-Density Lipoprotein Particles Related to the Risk of Coronary Heart Disease?

Krauss, R. M. (2002) · JAMA · doi:10.1001/jama.287.6.712 · Cited by 18 · see citing works

Dyslipidemia in obesity: Mechanisms and potential targets

Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665 · see citing works

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979 · see citing works

Dyslipidemia and cardiovascular disease risk among the MASHAD study population

Hedayatnia, M., Asadi, Z., Zare‐Feyzabadi, R., Yaghooti‐Khorasani, M., Ghazizadeh, H., Zirak, R. G., Tirkani, A. N., Mohammadi‐Bajgiran, M., Rohban, M., Sadabadi, F., et al. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01204-y · Cited by 406 · see citing works

Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans

Bhutani, S., Klempel, M. C., Kroeger, C. M., Trepanowski, J. F., & Varady, K. A. (2013) · Obesity · doi:10.1002/oby.20353 · Cited by 349 · see citing works

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

Pradhan, A. D., Paynter, N. P., Everett, B. M., Glynn, R. J., Amarenco, P., Elam, M., Ginsberg, H., Hiatt, W. R., Ishibashi, S., Koenig, W., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.09.011 · Cited by 319 · see citing works

Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis

Russell, J. C., & Proctor, S. D. (2006) · Cardiovascular Pathology · doi:10.1016/j.carpath.2006.09.001 · Cited by 317 · see citing works

Postprandial lipemia and cardiovascular disease risk: interrelationships between dietary, physiological and genetic determinants

Jackson, K. G., Poppitt, S. D., & Minihane, A. M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.012 · Cited by 246 · see citing works

Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus

Schwartz, E. A., Koska, J., Mullin, M. P., Syoufi, I., Schwenke, D. C., & Reaven, P. D. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.028 · Cited by 173 · see citing works

Postprandial lipoproteins and the molecular regulation of vascular homeostasis

Botham, K. M., & Wheeler-Jones, C. P. D. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.06.001 · Cited by 133 · see citing works

Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues

Sherratt, S. C. R., Libby, P., Budoff, M. J., Bhatt, D. L., & Mason, R. P. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01075-x · Cited by 150 · see citing works

Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis

Schwartz, E. A., & Reaven, P. D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.021 · Cited by 130 · see citing works

Comparison of effects of diet versus exercise weight loss regimens on LDL and HDL particle size in obese adults

Varady, K. A., Bhutani, S., Klempel, M. C., & Kroeger, C. M. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-119 · Cited by 116 · see citing works

Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins

Ansar, S., Koška, J., & Reaven, P. D. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-61 · Cited by 112 · see citing works

Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease

Duran, E. K., & Pradhan, A. D. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa296 · Cited by 108 · see citing works

Understanding Postprandial Inflammation and Its Relationship to Lifestyle Behaviour and Metabolic Diseases

Klop, B., Proctor, S. D., Mamo, J. C. L., Botham, K. M., & Cabezas, M. C. (2011) · International Journal of Vascular Medicine · doi:10.1155/2012/947417 · Cited by 93 · see citing works

Sphingomyelinase Induces Aggregation and Fusion of Small Very Low–Density Lipoprotein and Intermediate-Density Lipoprotein Particles and Increases Their Retention to Human Arterial Proteoglycans

Öörni, K., Posio, P., Ala‐Korpela, M., Jauhiainen, M., & Kovanen, P. T. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000168912.42941.60 · Cited by 93 · see citing works

Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: Increased atherogenicity for the metabolic syndrome

Vine, D. F., Takechi, R., Russell, J. C., & Proctor, S. D. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.013 · Cited by 88 · see citing works

Triglycerides and cardiovascular disease

Esan, O., & Wierzbicki, A. S. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000862 · Cited by 83 · see citing works

Transendothelial transport of lipoproteins

Jang, E., Robert, J., Rohrer, L., von Eckardstein, A., & Lee, W. L. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.09.020 · Cited by 83 · see citing works

Regulation of chylomicron production in humans

Xiao, C., & Lewis, G. F. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.09.019 · Cited by 80 · see citing works

Quantification of glucose diffusion in arterial tissues by using optical coherence tomography

Larin, K. V., Ghosn, M. G., Ivers, S. N., Téllez, A., & Granada, J. F. (2006) · Laser Physics Letters · doi:10.1002/lapl.200610111 · Cited by 73 · see citing works

Modification of lipoprotein metabolism and function driving atherogenesis in diabetes

Luciani, L., Pedrelli, M., & Parini, P. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117545 · Cited by 72 · see citing works

Pathophysiology of hypertriglyceridemia

Hassing, H. C., Surendran, R. P., Mooij, H. L., Stroes, E. S. G., Nieuwdorp, M., & Dallinga‐Thie, G. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.11.010 · Cited by 71 · see citing works

Dietary supplementation of n‐3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR:LA‐cp rat

Hassanali, Z., Ametaj, B. N., Field, C. J., Proctor, S. D., & Vine, D. F. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01130.x · Cited by 67 · see citing works

The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes

Thomas, M. C., Coughlan, M. T., & Cooper, M. E. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.004 · Cited by 62 · see citing works

Proteoglycan mediated lipoprotein retention: A mechanism of diabetic atherosclerosis

Tannock, L. R., & King, V. L. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9078-0 · Cited by 57 · see citing works

Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: The relationship to triglyceride-rich postprandial lipoprotein composition

Phillips, C. M., Mullan, K., Owens, D., & TOMKIN, G. H. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.08.020 · Cited by 52 · see citing works

Remarkable increase of apolipoprotein B48 level in diabetic patients with end-stage renal disease

Hayashi, T., Hirano, T., Taira, T., Tokuno, A., Mori, Y., Koba, S., & Adachi, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.015 · Cited by 53 · see citing works

Inflammatory Links Between Hypertriglyceridemia and Atherogenesis

Peng, X., & Wu, H. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01006-w · Cited by 51 · see citing works

Postprandial Dyslipidemia: Pathophysiology and Cardiovascular Disease Risk Assessment.

Higgins, V., & Adeli, K. (2017) · PubMed Central · Cited by 47 · see citing works

Targeting the vasculature in cardiometabolic disease

Boutagy, N. E., Singh, A. K., & Sessa, W. C. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148556 · Cited by 45 · see citing works

Chylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome

Mangat, R., Su, J. W., Scott, P. G., Russell, J. C., Vine, D. F., & Proctor, S. D. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350477 · Cited by 39 · see citing works

Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans

Mangat, R., Su, J. W., Lambert, J. E., Clandinin, M. T., Wang, Y., Uwiera, R. R. E., Forbes, J. M., Vine, D. F., Cooper, M. E., Mamo, J. C. L., et al. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03138.x · Cited by 39 · see citing works

The iterative lipid impact on inflammation in atherosclerosis

Kraaijenhof, J. M., Hovingh, G. K., Stroes, E. S. G., & Kroon, J. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000779 · Cited by 39 · see citing works

Elevated levels of platelet microparticles in carotid atherosclerosis and during the postprandial state

Michelsen, A. E., Notø, A. W., Brodin, E. E., Mathiesen, E. B., Brosstad, F. R., & Hansen, J. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.10.016 · Cited by 38 · see citing works

Omega-3-fatty acids: Do they prevent cardiovascular disease?

Mason, R. P., Sherratt, S. C. R., & Eckel, R. H. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101681 · Cited by 35 · see citing works

Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk

Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113499 · Cited by 35 · see citing works

Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model

Kupreeva, M., Diané, A., Lehner, R. S., Watts, R., Ghosh, M., Proctor, S. D., & Vine, D. F. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00018.2018 · Cited by 34 · see citing works

Intestinal lipid transport and chylomicron production: Possible links to exacerbated atherogenesis in a rodent model of the metabolic syndrome

Vine, D. F., Glimm, D. R., & Proctor, S. D. (2008) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2008.05.004 · Cited by 34 · see citing works

Spatial Distributions of Lipids in Atherosclerosis of Human Coronary Arteries Studied by Time-of-Flight Secondary Ion Mass Spectrometry

Lehti, S., Sjövall, P., Käkelä, R., Mäyränpää, M. I., Kovanen, P. T., & Öörni, K. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.01.026 · Cited by 31 · see citing works

Degradation of the endothelial glycocalyx is associated with chylomicron leakage in mouse cremaster muscle microcirculation

Constantinescu, A. A., Spaan, J. A. E., Arkenbout, E. K., Vink, H., & VanTeeffelen, J. W. G. E. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-08-0560 · Cited by 29 · see citing works

Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins

Araujo, G., Valencia, L. M., Martin-Ozimek, A., Soto, Y., & Proctor, S. D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1485801 · Cited by 29 · see citing works

Triglyceride-Rich Lipoproteins as a Source of Proinflammatory Lipids in the Arterial Wall

Öörni, K., Lehti, S., Sjövall, P., & Kovanen, P. T. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180530094819 · Cited by 28 · see citing works

Arterial Retention of Remnant Lipoproteins Ex Vivo Is Increased in Insulin Resistance Because of Increased Arterial Biglycan and Production of Cholesterol‐Rich Atherogenic Particles That Can Be Improved by Ezetimibe in the JCR:LA‐ cp Rat

Mangat, R., Warnakula, S., Borthwick, F., Hassanali, Z., Uwiera, R. R. E., Russell, J. C., Cheeseman, C. I., Vine, D. F., & Proctor, S. D. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.003434 · Cited by 26 · see citing works

Remnant cholesterol is more positively related to diabetes, prediabetes, and insulin resistance than conventional lipid parameters and lipid ratios: A multicenter, large sample survey

Li, B., Liu, Y., Zhou, X. J., Chen, L., Yan, L., Tang, X., Gao, Z., Wan, Q., Luo, Z., Qin, G., et al. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13592 · Cited by 27 · see citing works

Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and Peroxisome Proliferator-Activated Receptor Alpha Agonists and Ezetimibe for Its Treatment

Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073418 · Cited by 25 · see citing works

ApoA-1 infusion reduces arterial cholesterol and myocardial lesions in a rat model of cardiac dysfunction and insulin resistance

Borthwick, F., Warnakula, S., Mangat, R., Uwiera, R. R. E., Russell, J. C., Kelly, S. E., Lee, C. Y. W., Hryshko, L. V., Mamo, J. C. L., Rye, K., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.03.006 · Cited by 24 · see citing works

The intestine as a regulator of cholesterol homeostasis in diabetes

TOMKIN, G. H. (2008) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2008.05.012 · Cited by 24 · see citing works

In vivo evidence for chylomicrons as mediators of postprandial inflammation

de Vries, M. A., Klop, B., Alipour, A., van de Geijn, G. M., Prinzen, L., Liem, A. H., Valdivielso, P., Rioja, J., Ramírez‐Bollero, J., & Cabezas, M. C. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.025 · Cited by 24 · see citing works

The Apolipoprotein C-I Content of Very-Low-Density Lipoproteins Is Associated with Fasting Triglycerides, Postprandial Lipemia, and Carotid Atherosclerosis

Hansen, J., Fernández, J. A., Notø, A. W., Deguchi, H., Björkegren, J., & Mathiesen, E. B. (2011) · Journal of Lipids · doi:10.1155/2011/271062 · Cited by 24 · see citing works

Postprandial Lipid Metabolism: The Missing Link Between Life-Style Habits and the Increasing Incidence of Metabolic Diseases in Western Countries?~!2009-09-30~!2010-01-26~!2010-03-30~!

Bravo, E., Napolitano, M., & Botham, K. M. (2010) · The Open Translational Medicine Journal · doi:10.2174/1876399501002010001 · Cited by 25 · see citing works

New Therapeutic Approaches to the Treatment of Dyslipidemia 1: ApoC-III and ANGPTL3

Kim, J. Y., & Kim, N. H. (2023) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2023.12.1.23 · Cited by 23 · see citing works

Pair feeding-mediated changes in metabolism: stress response and pathophysiology in insulin-resistant, atherosclerosis-prone JCR:LA-cp rats

Russell, J. C., Proctor, S. D., Kelly, S. E., & Brindley, D. N. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90257.2008 · Cited by 22 · see citing works

Acidity and lipolysis by group V secreted phospholipase A2 strongly increase the binding of apoB-100-containing lipoproteins to human aortic proteoglycans

Lähdesmäki, K., Öörni, K., Alanne-Kinnunen, M., Jauhiainen, M., Hurt‐Camejo, E., & Kovanen, P. T. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.014 · Cited by 22 · see citing works

Postprandial dyslipidemia in insulin resistant states in adolescent populations

Higgins, V., & Adeli, K. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20190094 · Cited by 20 · see citing works

The role of triglycerides in the origin and progression of atherosclerosis

Padró, T., Muñoz‐García, N., & Badimón, L. (2021) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2021.02.007 · Cited by 21 · see citing works

New Insights Into How the Intestine Can Regulate Lipid Homeostasis and Impact Vascular Disease: Frontiers for New Pharmaceutical Therapies to Lower Cardiovascular Disease Risk

Warnakula, S., Hsieh, J., Adeli, K., Hussain, M. M., Tso, P., & Proctor, S. D. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.12.020 · Cited by 19 · see citing works

Increased Apolipoprotein Deposits in Early Atherosclerotic Lesions Distinguish Symptomatic From Asymptomatic Patients

von Ballmoos, M. C. W., Dubler, D., Mirlacher, M., Cathomas, G., Muser, J., & Biedermann, B. C. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000198250.91406.6d · Cited by 19 · see citing works

Delayed clearance of triglyceride‐rich lipoproteins in young, healthy obese subjects

Larsen, M. A., Goll, R., Lekahl, S., Moen, O. S., & Florholmen, J. R. (2015) · Clinical Obesity · doi:10.1111/cob.12118 · Cited by 18 · see citing works

Rimonabant-mediated changes in intestinal lipid metabolism and improved renal vascular dysfunction in the JCR:LA-cprat model of prediabetic metabolic syndrome

Russell, J. C., Kelly, S. E., Diané, A., Wang, Y., Mangat, R., Novak, S., Vine, D. F., & Proctor, S. D. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00173.2010 · Cited by 17 · see citing works

SPPARM alpha: the Lazarus effect

Fruchart, J., & Santos, R. D. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000640 · Cited by 16 · see citing works

Irbesartan‐mediated reduction of renal and cardiac damage in insulin resistant JCR : LA‐cprats

Russell, J., Kelly, S., Vine, D. F., & Proctor, S. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00417.x · Cited by 14 · see citing works

Role of Altered Metabolism of Triglyceride-Rich Lipoprotein Particles in the Development of Vascular Dysfunction in Systemic Lupus Erythematosus

Diószegi, Á., Lőrincz, H., Kaáli, E., Soltész, P., Perge, B., Varga, É., Harangi, M., & Tarr, T. (2023) · Biomolecules · doi:10.3390/biom13030401 · Cited by 13 · see citing works

Significant Increase of Apolipoprotein B48 Levels by a Standard Test Meal in Type 2 Diabetic Patients with Nephropathy

Yamamoto, T., Hirano, T., Mori, Y., Tokuno, A., Nagashima, M., Takada, M., Morita, R., Lee, S., Hayashi, T., & Adachi, M. (2008) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e558 · Cited by 13 · see citing works

Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?

Nicholls, S. J., & Scherer, D. J. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s40134 · Cited by 12 · see citing works

Elastic Fiber Fragmentation Increases Transmural Hydraulic Conductance and Solute Transport in Mouse Arteries

Cocciolone, A. J., Johnson, E. O., Shao, J., & Wagenseil, J. E. (2018) · Journal of Biomechanical Engineering · doi:10.1115/1.4042173 · Cited by 12 · see citing works

Increased Postprandial Triglyceride‐Rich Lipoprotein Levels in Elderly Survivors of Myocardial Infarction

Lekhal, S., Børvik, T., Nordøy, A., & Hansen, J. (2008) · Lipids · doi:10.1007/s11745-008-3165-6 · Cited by 12 · see citing works

Association between Intermediate-Density Lipoprotein Particles and the Progression of Carotid Atherosclerosis: A Community-Based Cohort Study

Liu, T., Zhao, D., Wang, M., Sun, J., Liu, J., Li, J., Duan, Y., Hu, P., Sun, Z., Liu, J., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.63937 · Cited by 11 · see citing works

Model of intestinal chylomicron over-production and Ezetimibe treatment: Impact on the retention of cholesterol in arterial vessels

Mangat, R., Warnakula, S., Wang, Y., Russell, J. C., Uwiera, R. R. E., Vine, D. F., & Proctor, S. D. (2010) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2010.04.043 · Cited by 11 · see citing works

Dietary fat and physiological determinants of plasma chylomicron remnant homoeostasis in normolipidaemic subjects: insight into atherogenic risk

Irawati, D., Mamo, J. C. L., Clark, K., Soares, M. J., & James, A. P. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517000150 · Cited by 10 · see citing works

Atherogenic ApoB-dyslipidemia, atherosclerotic cardiovascular disease, cardiac dysfunction and remodeling in high-risk young women with and without polycystic ovary syndrome: A pilot study

Wu, X., Wilke, M., Batara, J., Proctor, S. D., Cree‐Green, M., Ghosh, M., Raggi, P., Windram, J. D., Becher, H. H., & Vine, D. F. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1520922 · Cited by 9 · see citing works

Delayed Metabolism of Postprandial Triglyceride‐Rich Lipoproteins in Subjects with Echolucent Carotid Plaques

Notø, A. W., Mathiesen, E. B., Brox, J. H., Björkegren, J., & Hansen, J. (2008) · Lipids · doi:10.1007/s11745-008-3159-4 · Cited by 9 · see citing works

Triglicéridos, colesterol HDL y dislipidemia aterogénica en la guía europea para el control de las dislipidemias 2019

Pedro‐Botet, J., Ascaso, J. F., Blasco, M., Brea, Á., Rodríguez, Á. D., Hernández‐Mijares, A., Pintó, X., & Millán, J. (2020) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2019.12.003 · Cited by 9 · see citing works

Predictive utility of remnant cholesterol in atherosclerotic cardiovascular disease

Proctor, S. D., Wang, M., Vine, D. F., & Raggi, P. (2024) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001140 · Cited by 9 · see citing works

Associations of intra‐pancreatic fat deposition with triglyceride‐rich lipoproteins and lipoprotein lipase

Liu, Y., Skudder‐Hill, L., Kimita, W., Shamaitijiang, X., Sequeira, I. R., & Petrov, M. S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16338 · Cited by 6 · see citing works

Thyroid Function Influences Serum Apolipoprotein B-48 Levels in Patients with Thyroid Disease

Mugii, S., Hanada, H., Okubo, M., Masuda, D., Takeoka, K., Hidaka, Y., Ohama, T., Matsuyama, A., Nakagawa-Toyama, Y., Nishida, M., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12757 · Cited by 6 · see citing works

Phospholipase A2 Mediates Apolipoprotein-Independent Uptake of Chylomicron Remnant-Like Particles by Human Macrophages

Napolitano, M., Kruth, H. S., & Bravo, E. (2011) · International Journal of Vascular Medicine · doi:10.1155/2012/501954 · Cited by 6 · see citing works

Transport across the thoracic aortic wall: implications for aneurysm pathobiology, diagnosis, and treatment

Kailash, K. A., Akanda, S. R., Davis, A. L., Crandall, C. L., Zaghloul, M. S., Setton, L. A., Halabi, C. M., Zayed, M. A., & Wagenseil, J. E. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00886.2024 · Cited by 5 · see citing works

Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin‐Resistant Rats: Acute Treatment Versus Long‐Term Protection as an Idiotypic Vaccine for Atherosclerosis

Soto, Y., Hernández, A., Sarduy, R., Navarro, V. B., Marleau, S., Vine, D. F., Vázquez, A. M., & Proctor, S. D. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032419 · Cited by 5 · see citing works

Functional foods and coronary heart disease (CHD)

Lovegrove, J. A., & Jackson, K. G. (2011) · Elsevier eBooks · doi:10.1533/9780857092557.2.153 · Cited by 5 · see citing works

Roles of Achieved Levels of Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein on Cardiovascular Outcome in Statin Therapy

Hyun, M. H., Lee, Y.-C., Choi, B. G., Na, J. O., Choi, C. U., Kim, J. W., Kim, E. J., Rha, S., Park, C. G., Lee, E. M., et al. (2019) · Cardiovascular Therapeutics · doi:10.1155/2019/3824823 · Cited by 5 · see citing works

Decreased lipoprotein lipase activity and increased postprandial concentrations of triglyceride-rich lipoproteins in offspring of elderly survivors of myocardial infarction

Lekhal, S., Børvik, T., Nordøy, A., & Hansen, J. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.10.001 · Cited by 5 · see citing works

Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias

Pedro‐Botet, J., Ascaso, J. F., Blasco, M., Brea, Á., Díaz, Á., Hernández‐Mijares, A., Pintó, X., & Millán, J. (2020) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2019.12.001 · Cited by 4 · see citing works

Postprandial lipemia and the relationship to health

Huggins, C. E., James, A. P., Bonham, M. P., Clark, K., & Lee, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823914-8.00019-7 · Cited by 3 · see citing works

Postprandial implications in cardiovascular disease and potential markers to develop new therapies

Tudorache, I. F., Barbarossa, D., Daraban, B. S., Rizzo, R., Esposito, F. M., Coronelli, M. M., & Catapano, A. L. (2025) · European Atherosclerosis Journal · doi:10.56095/eaj.v4i2.104 · Cited by 2 · see citing works

Vascular Biology of the Metabolic Syndrome

Lee, J., & Choudhury, R. P. (2006) · CRC Press eBooks · doi:10.3109/9781420020601-5 · Cited by 2 · see citing works

Stochastic Models for Prodrug Targeting. 1. Diffusion of the Efflux Drug

Qi, X. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050089l · Cited by 1 · see citing works

Macro- and Microvascular Disease in an Insulin-Resistant Pre-Diabetic Animal Model

Russell, J. C., & Proctor, S. D. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_8 · Cited by 1 · see citing works

Role of angiopoietin-like 3 and 4 in triacylglycerol metabolism : from population studies to molecular mechanisms of action

Robciuc, M. R. (2012) · Työväentutkimus Vuosikirja

Experimental and computational studies on lipoprotein lipolysis at acidic pH

Lähdesmäki, K. (2010) · Työväentutkimus Vuosikirja

Efeitos da dieta vegetariana no metabolismo de quilomícrons e aspectos qualitativos da lipoproteína de alta densidade (HDL)

Vinagre, J. C. (2010) · doi:10.11606/t.5.2010.tde-21122010-120737

Avaliação do metabolismo de quilomícrons artificiais em pacientes obesas e não obesas, portadoras da síndrome dos ovários policísticos

Rocha, M. P. (2007) · doi:10.11606/t.5.2007.tde-11032008-161037

Intestinal postprandial chylomicrons: state of the union between liver, gut and dyslipidemia?

Proctor, S. D., Vine, D. F., Botham, K. M., Mamo, J. C. L., & Cabezas, M. C. (2008) · Future Lipidology · doi:10.2217/17460875.3.5.473

Cholesterol metabolism and noncholesterol sterol distribution in lipoproteins of Type 1 diabetes

Suryadevara, R. S. (2008) · Future Lipidology · doi:10.2217/17460875.3.1.17

Multigene Assays: The Changing Paradigm of Personalized Medicine in Breast Cancer

Gaur, G. (2017) · MOJ Cell Science & Report · doi:10.15406/mojcsr.2017.04.00097

The role of novel red yeast rice formulation to modulate lipid metabolism and reduce dyslipidemia and vascular disease in the JCR:LA-cp rat

Wu, S. (2013) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3xk84x3b

2型糖尿病におけるエゼチミブの小型高密度低比重リポ蛋白低下作用 トリグリセリド-リッチリポ蛋白との関係

賀子, 原., & Hara, N. (2014) · 糖尿病 · doi:10.11213/tonyobyo.57.1

Nutritional Factors Impacting Intestinal Lipid Metabolism Using a Model of Low Birth Weight Swine

Fontaine, M. A. (2018) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3dr2pq51

Differentiation of submicron particles in blood plasma of farm poultry by optical method and multivariate regression method

Lovtsova, L. G., Zabelina, M. V., Lovtsov, I. V., & Uskov, K. Y. (2023) · AIP conference proceedings · doi:10.1063/5.0148365

Monoclonal antibody chP3R99 reduces subendothelial retention of atherogenic lipoproteins in Insulin-Resistant rats: Acute treatment versus long-term protection as an idiotypic vaccine for atherosclerosisPreprint

Soto, Y., Hernández, A., Sarduy, R., Brito, V., Marleau, S., Vine, D. F., Vázquez, A. M., & Proctor, S. D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.30.555546

Arterial fatty lesions have increased uptake of chylomicron remnants but not low-density lipoproteins.

Proctor, S. D., & Mamo, J. C. L. (1996) · PubMed · Cited by 58 · see citing works

Abstract 672: Reduced "Egress" of Remnant Lipoproteins From Arterial Tissue Relative to LDL During Insulin Resistance May Explain a Preferential Role in Atherosclerosis Progression

Mangat, R., Borthwick, F., Vine, D. F., & Proctor, S. D. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvb.34.suppl_1.672

Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentrations, extent of aortic lesion, and lipoprotein particle size as determinants.

Nordestgaard, B. G., Tybjaerg-Hansen, A., & Lewis, B. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.1.6 · Cited by 159 · see citing works

Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin

Mamo, J. C. L., & Wheeler, J. R. (1994) · Coronary Artery Disease · doi:10.1097/00019501-199408000-00008 · Cited by 100 · see citing works

Evaluation of the Permeability Parameters (Influx, Efflux and Volume of Distribution) of Arterial Wall for LDL and Other Proteins

Ghosh, S., Finkelstein, J. N., Moss, D., & Schweppe, J. S. (1976) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4618-7_11 · Cited by 16 · see citing works